April 20. In what can become a ground breaking move towards availability of vaccines in Argentina, the Russian Government authorized an Argentine firm to produced test batches of Russia’s Sputnik-V COVID-19 vaccine, with a goal of scaling up manufacturing of the vaccine by mid-year as it grapples with resurgence of Covid-19 infections.
Limited foreign currency reserve and poor sovereign credit rating of Argentina have encumbered the Government’s ability to mount an effective vaccination campaign.
Russian sovereign wealth fund RDIF and Laboratories Richmond (RICH.BA) said on Tuesday that the Argentina pharmaceutical company had carried out the test production and that the batches would be sent to Russia’s Gamaleya Institute for quality inspection.
“We estimate that, if the process is positive, scale production would begin in June 2021,” Richmond said in a statement, adding it aimed to have the vaccine ready “in the shortest possible time for the country and the region.”
Argentina’s inoculation program has relied heavily on Sputnik V. The South American country was one of the first globally to use the vaccine on scale to inoculate its population and has faced delays getting other vaccines.
Photo: El Nacional